Pharmacology of major neurological drugs
Antiparkinsonian
| Class | Agents | Position |
|---|---|---|
| Levodopa + peripheral DDCI | Carbidopa, benserazide | Most effective for bradykinesia and rigidity; recommended first agent at any age. Motor fluctuations and dyskinesia with time |
| Dopamine agonists (non-ergot) | Pramipexole, ropinirole, rotigotine patch, apomorphine | Levodopa-sparing; impulse control disorders ~15-20% |
| Ergot agonists | Bromocriptine, pergolide, cabergoline | *Avoid - cardiac valvulopathy and retroperitoneal/pulmonary fibrosis* |
| MAO-B inhibitors | Rasagiline, selegiline, safinamide | Less effective than levodopa; useful early or as adjunct |
| COMT inhibitors | Entacapone (with each dose), opicapone (once daily), tolcapone | Prolong levodopa "on" time. Tolcapone: hepatotoxicity, restricted |
| Amantadine | The drug for dyskinesia | |
| Anticholinergics | Benztropine, trihexyphenidyl | Tremor only, in the young. Avoid over 65 |
19 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access